Thank you for subscribing!
Catalyst Hunter Archived Dec 16, 2020
Neurotech International Ltd (ASX: NTI) is focused on the clinical applications of unique cannabis strains to treat neurological disorders such as autism and is set to commence human clinical trials early in 2021.
Get expert stock analysis direct in your inbox
Join Our Mailing List